Clinical Trial 11999

San Antonio, TX 78209

Study Summary:

ICON Development Solutions is recruiting postmenopausal females ages 45-75 with osteoporosis, for a clinical research study. The purpose of the study is to test the safety and tolerability of an investigational medication. The study drug is being developed for the treatment of osteoporosis in postmenopausal females and will be given as an intramuscular injection.

Vital signs, ECGs, physical examinations, DEXA Scans, ultrasounds, blood and urine samples will be obtained and performed during this study.

Qualified Participants Must:

• Be female
• Be 45-75 years of age
• Have osteoporosis
• Weigh less than 300 pounds
• Be postmenopausal (no period for at least 2 years)
• Have not been treated with any oral osteoporosis medications in the past 6 months or injectable osteoporosis medications in the past 12 months
• Complete up to 2 screening visits and 11 overnight visits (non-consecutive)

Qualified Participants May Receive:

All study related exams, including DEXA scan, at no cost and compensation up to $2,640 for time and travel.

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.